(Q41183184)

27 September 2017

title

Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma (English)

1 reference

27 September 2017

Sunyoung Lee

1

1 reference

27 September 2017

Hyunchul Rhim

2

1 reference

27 September 2017

Young-sun Kim

3

1 reference

27 September 2017

Tae Wook Kang

4

1 reference

27 September 2017

Kyoung Doo Song

5

1 reference

27 September 2017

publication date

26 October 2015

1 reference

27 September 2017

1 reference

27 September 2017

volume

36

1 reference

27 September 2017

issue

4

1 reference

27 September 2017

page(s)

580-587

1 reference

Hepatocellualar carcinoma serum markers

27 September 2017

cites work

1 reference

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

alpha-fetoprotein in noneoplastic hepatic disorders

21 January 2018

1 reference

Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma

21 January 2018

1 reference

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

21 January 2018

1 reference

Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis

21 January 2018

1 reference

Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

21 January 2018

1 reference

Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.

21 January 2018

1 reference

Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: relationship to prognosis

21 January 2018

1 reference

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

21 January 2018

1 reference

Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes.

21 January 2018

1 reference

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

21 January 2018

1 reference

Model for End-stage Liver Disease

21 January 2018

1 reference

Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells.

21 January 2018

1 reference

Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma

21 January 2018

1 reference

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC

21 January 2018

1 reference

PIVKA-II Is the Best Prognostic Predictor in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation Therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12991

1 reference

27 September 2017

1 reference